Chorea

Page most recently updated 7 September 2026

This page reviews the differential diagnosis of chorea in the context of presentations with psychiatric symptoms, focusing on conditions in which both may occur together. It begins by defining chorea and related hyperkinetic movements and outlining initial diagnostic considerations before examining the broader differential diagnosis. Of note, benign hereditary chorea and chorea gravidarum are not included in the differential below because they are not typically associated with psychiatric features.

Description

Chorea is a hyperkinetic movement disorder consisting of involuntary movements that are rapid, nonpatterned, and flow from one body part to another, often involving the distal limbs but also potentially involving the face and trunk.

In terms of distinction from other movement phenotypes:

The greater rapidity distinguishes it from athetosis, which consists of slower, continuous, writhing movements.
The nonpatterned nature (random, unpredictable) distinguishes it from
tremor , in that it is irregular and unpredictable in timing, speed and direction.
The nonpatterned, flowing quality distinguishes it from
dystonia , which produces patterned movements and/or abnormal postures.
The typically smaller-amplitude and more distal distribution distinguishes it from ballism, which is characterised by large-amplitude, predominantly proximal movements.

Chorea may be considered along a spectrum of hyperkinetic movements that includes athetosis and ballism.

Athetosis also typically involves the distal extremities and consists of slower, continuous, writhing movements. These movements can cooccur with those of chorea; a pattern called choreoathetosis.
Ballism, by contrast, tends to involve the proximal extremities with large-amplitude involuntary movements, often unilateral (hemiballism), resembling flinging of the upper limb or kicking with the lower limb.

Initial considerations

Huntington disease is an important diagnosis to consider in adults presenting with chorea, as it is the most common cause of chronic progressive chorea in adults and the most common hereditary cause of chorea. Other hereditary neurodegenerative disorders can produce similar clinical presentations. Acquired causes of chorea, including cerebrovascular disease, autoimmune disorders, and medications, should also be considered, particularly when the onset is acute or subacute, the clinical features are atypical, or there are other neurologic or systemic features suggesting an alternative diagnosis.

Although this section is primarily concerned with chronic chorea in adults, clinicians should remain vigilant for acute or sudden-onset chorea, particularly hemichorea, which may represent a medical emergency and therefore requires prompt assessment. Cerebrovascular disease, including basal ganglia ischemic or hemorrhagic stroke, is an important consideration, as are other potentially treatable causes such as non-ketotic hyperglycemia.

Broader differentials

● From a cognitive lens perspective

◦ Huntington disease

◦ C9ORF72 repeat expansions

◦ Huntington disease-like syndromes (HDL1–4)

◦ Spinocerebellar ataxias (SCAs), particularly SCA1, SCA2, SCA3, SCA8, SCA12, SCA17, and SCA48

◦ Dentatorubral pallidoluysian atrophy (DRPLA)

◦ Neurodegenerative disorders with brain iron accumulation (NBIA)

Pantothenate kinase-associated neurodegeneration (PKAN)

Neuroferritinopathy

Aceruloplasminemia

● From a lesional lens perspective

Structural abnormalities affecting the basal ganglia or their connections can result in chorea. Examples include traumatic, neoplastic and vascular lesions. Basal ganglia ischemia and haemorrhage can present with acute chorea, particularly hemichorea, and are medical emergencies requiring urgent assessment.

● Other differentials (including multisystemic conditions )

● Intrinsic

Immune-mediated

◦ Autoimmune (and paraneoplastic) disorders

Anti-CV2/CRMP5-associated neurological syndrome

Anti-Hu-associated neurological syndrome

Anti-NMDA receptor encephalitis

Anti-PDE10A-associated chorea

Anti-IgLON5 disease

Anti-CASPR2-associated neurological syndrome

Anti-LGI1 encephalitis

Anti-GABA-B receptor encephalitis

Anti-Ri-associated neurological syndrome

Anti-Yo-associated neurological syndrome

◦ Connective tissue diseases

Systemic lupus erythematosus

◦ Systemic vasculitides

Behçet disease

◦ Other immune-mediated disorders

Sydenham chorea

Antiphospholipid syndrome

Celiac disease

Endocrine

◦ Hyperthyroidism

◦ Hyperparathyroidism (and other causes of hypercalcemia)

Genetic

(in addition to genetic conditions mentioned above with the cognitive lens)

◦ Neuroacanthocytoses (particularly chorea-acanthocytosis and McLeod syndrome)

◦ Ataxia-telangiectasia

◦ Ataxia with oculomotor apraxia (AOA) types 1 (AOA1) or 2 (AOA2)

◦ Friedreich ataxia

◦ Primary familial brain calcification (PFBC; formerly referred to as familial idiopathic basal ganglia calcification or Fahr disease)

◦ Neurometabolic disorders

Wilson disease

Lesch-Nyhan syndrome

Neoplastic

◦ Polycythemia vera

Other

◦ Functional movement disorder

● Extrinsic

Toxic and deficiency states

◦ Drug-induced

Tardive dyskinesia associated with dopamine receptor-blocking agents

Levodopa-induced dyskinesia (in patients with Parkinson disease)

Estrogen-sensitive chorea

Oral contraceptive-induced chorea (particularly in patients with previous Sydenham chorea, chorea gravidarum, SLE, or antiphospholipid syndrome)

Hormone replacement therapy-induced chorea (particularly in postmenopausal women with a previous history of chorea)

Toxic exposures/poisoning

Carbon monoxide, manganese, thallium , or mercury poisoning

Alcohol and recreational drug use, including amphetamines, cocaine, heroin, and inhaled volatile solvents (“glue-sniffing”)

◦ Deficiency states

Vitamin B12 deficiency

Infectious

◦ Bacterial

Neurosyphilis

Lyme neuroborreliosis

◦ Viral

Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS)

◦ Parasitic

Toxoplasmosis

Neurocysticercosis

◦ Other

Prion diseases (particularly variant Creutzfeldt–Jakob disease [vCJD] and, less commonly, sporadic [sCJD] or genetic CJD [gCJD])

Selected references and further reading — Movement lens

Jankovic J, Hallett M, Okun MS, Comella CL, Fahn S. Principles and practice of movement disorders. 3rd ed. Philadelphia: Elsevier; 2021.

Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, editors. Bradley and Daroff's neurology in clinical practice. 8th ed. Philadelphia: Elsevier; 2022.

Campbell WW. DeJong's the neurologic examination. 8th ed. Philadelphia: Wolters Kluwer; 2020.

Arciniegas DB, Yudofsky SC, Hales RE, editors. The American Psychiatric Association Publishing textbook of neuropsychiatry and clinical neurosciences. 6th ed. Washington (DC): American Psychiatric Association Publishing; 2018.

Agrawal N, Faruqui R, Bodani M, editors. Oxford textbook of neuropsychiatry. Oxford: Oxford University Press; 2020.

Dening T, Thomas A, editors. Oxford textbook of old age psychiatry. 3rd ed. Oxford: Oxford University Press; 2021.

Blazer DG, Steffens DC, Busse EW, editors. The American Psychiatric Publishing textbook of geriatric psychiatry. 5th ed. Washington (DC): American Psychiatric Publishing; 2015.